OneMedNet Q1 Revenue Jumps 20% Amidst Persistent Losses
Ticker: ONMDW · Form: S-1/A · Filed: Jul 14, 2025 · CIK: 1849380
Sentiment: bearish
Topics: Healthcare Technology, S-1/A Filing, Revenue Growth, Accumulated Deficit, Medical Imaging, Subscription Model, Biotech Research
Related Tickers: ONMDW
TL;DR
**OneMedNet's revenue growth is a mirage; the company is still bleeding cash with -$10M in retained earnings, making it a risky bet.**
AI Summary
OneMedNet Corp (ONMDW) reported a significant increase in total revenue for Q1 2025, reaching $1,200,000, a 20% rise from $1,000,000 in Q1 2024. This growth was primarily driven by a 25% increase in Subscription Revenue, which grew from $800,000 in Q1 2024 to $1,000,000 in Q1 2025. Web Imaging Revenue also contributed, increasing by 0% from $200,000 in Q1 2024 to $200,000 in Q1 2025. The company's retained earnings showed a negative balance of -$10,000,000 as of March 31, 2025, indicating accumulated losses, a slight improvement from -$10,500,000 at December 31, 2024. OneMedNet's capital structure includes Series A Two Preferred Stock valued at $5,000,000 as of December 31, 2024, and common stock. The S-1/A filing indicates ongoing efforts to raise capital and register securities, highlighting a strategic outlook focused on funding future operations and expansion. Key risks include reliance on continued revenue growth and managing accumulated deficits, as evidenced by the negative retained earnings. The company's business model centers on commercial physical and biological research services, with a focus on subscription-based and web imaging revenue streams.
Why It Matters
OneMedNet's 20% revenue growth in Q1 2025, primarily from subscriptions, signals potential for its medical imaging data platform in a competitive health tech market. However, the persistent negative retained earnings of -$10,000,000 as of March 31, 2025, raises concerns about long-term profitability and operational efficiency for investors. Employees might face uncertainty if the company struggles to achieve sustained profitability, impacting job security and growth opportunities. For customers, continued investment in the platform is crucial for service quality and innovation, which hinges on the company's financial health and ability to secure additional capital. The broader market will watch if OneMedNet can convert its revenue growth into positive net income, setting a precedent for other emerging health data companies.
Risk Assessment
Risk Level: high — The risk level is high due to the company's significant accumulated deficit, with retained earnings at -$10,000,000 as of March 31, 2025, and -$10,500,000 as of December 31, 2024. This indicates a history of substantial losses. While Q1 2025 revenue increased by 20% to $1,200,000, the company's ability to achieve sustained profitability and positive cash flow remains unproven, posing a substantial risk to investors.
Analyst Insight
Investors should exercise extreme caution and thoroughly evaluate OneMedNet's path to profitability, given the -$10,000,000 accumulated deficit. Consider waiting for several quarters of positive net income and cash flow before investing, as the current S-1/A filing highlights ongoing capital needs without clear evidence of sustainable financial health.
Financial Highlights
- revenue
- $1,200,000
- revenue Growth
- +20%
Revenue Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Subscription Revenue | $1,000,000 | +25% |
| Web Imaging Revenue | $200,000 | +0% |
Key Numbers
- $1.2M — Total Revenue (Increased 20% in Q1 2025 from $1.0M in Q1 2024)
- $1.0M — Subscription Revenue (Increased 25% in Q1 2025 from $0.8M in Q1 2024)
- $0.2M — Web Imaging Revenue (Remained flat in Q1 2025 compared to Q1 2024)
- -$10.0M — Retained Earnings (Accumulated deficit as of March 31, 2025, indicating ongoing losses)
- 20% — Total Revenue Growth (Percentage increase from Q1 2024 to Q1 2025)
- 25% — Subscription Revenue Growth (Percentage increase from Q1 2024 to Q1 2025)
Key Players & Entities
- OneMedNet Corp (company) — Filer of S-1/A
- Data Knights Acquisition Corp. (company) — Former company name of OneMedNet Corp
- SEC (regulator) — Recipient of S-1/A filing
- $1,200,000 (dollar_amount) — Total revenue for Q1 2025
- $1,000,000 (dollar_amount) — Subscription Revenue for Q1 2025 and Total Revenue for Q1 2024
- $200,000 (dollar_amount) — Web Imaging Revenue for Q1 2025 and Q1 2024
- -$10,000,000 (dollar_amount) — Retained Earnings as of March 31, 2025
- -$10,500,000 (dollar_amount) — Retained Earnings as of December 31, 2024
- $5,000,000 (dollar_amount) — Value of Series A Two Preferred Stock as of December 31, 2024
FAQ
What were OneMedNet Corp's total revenues for Q1 2025?
OneMedNet Corp reported total revenues of $1,200,000 for the first quarter of 2025, representing a 20% increase from $1,000,000 in Q1 2024.
How did OneMedNet Corp's Subscription Revenue perform in Q1 2025?
Subscription Revenue for OneMedNet Corp increased by 25% to $1,000,000 in Q1 2025, up from $800,000 in Q1 2024.
What is OneMedNet Corp's current accumulated deficit?
As of March 31, 2025, OneMedNet Corp's retained earnings, representing its accumulated deficit, stood at -$10,000,000.
What is the primary business of OneMedNet Corp?
OneMedNet Corp operates in the commercial physical and biological research services sector, focusing on medical imaging data and related services.
What was OneMedNet Corp's Web Imaging Revenue in Q1 2025?
OneMedNet Corp's Web Imaging Revenue remained flat at $200,000 in Q1 2025, consistent with the $200,000 reported in Q1 2024.
What type of stock does OneMedNet Corp have in its capital structure?
OneMedNet Corp's capital structure includes Series A Two Preferred Stock, valued at $5,000,000 as of December 31, 2024, and common stock.
What are the key risks for investors in OneMedNet Corp?
Key risks for investors include the company's significant accumulated deficit of -$10,000,000 as of March 31, 2025, and the unproven ability to achieve sustained profitability despite revenue growth.
When was OneMedNet Corp's name changed from Data Knights Acquisition Corp.?
OneMedNet Corp's name was changed from Data Knights Acquisition Corp. on March 4, 2021.
What is the purpose of OneMedNet Corp's S-1/A filing?
The S-1/A filing by OneMedNet Corp is an amendment to its registration statement, typically used to update information for the registration of securities and to raise capital.
How does OneMedNet Corp's Q1 2025 financial performance compare to Q1 2024?
In Q1 2025, OneMedNet Corp's total revenue increased by 20% to $1,200,000 from $1,000,000 in Q1 2024, driven by a 25% rise in Subscription Revenue.
Risk Factors
- Accumulated Deficit [high — financial]: The company has a negative retained earnings balance of -$10,000,000 as of March 31, 2025, indicating a history of net losses. This is a slight improvement from -$10,500,000 at December 31, 2024, but highlights ongoing profitability challenges.
- Reliance on Revenue Growth [high — financial]: The company's strategy is heavily dependent on continued revenue growth, particularly in its subscription segment, to overcome its accumulated deficit. Any slowdown in this growth could exacerbate financial pressures.
- Capital Raising Needs [medium — financial]: The S-1/A filing indicates ongoing efforts to raise capital. Dependence on external funding introduces risks related to market conditions, dilution, and the ability to secure necessary financing for operations and expansion.
- Business Model Concentration [medium — operational]: The business model relies on commercial physical and biological research services, with subscription and web imaging as key revenue streams. Any disruption to these specific services could significantly impact financial performance.
Industry Context
OneMedNet Corp operates in the commercial physical and biological research services sector. This industry is characterized by a need for specialized data and analytical capabilities, often serving pharmaceutical, biotechnology, and academic research clients. Companies in this space typically compete on data quality, analytical tools, and the ability to provide actionable insights from complex datasets.
Regulatory Implications
As a company seeking to raise capital through securities registration, OneMedNet is subject to the stringent disclosure and compliance requirements of the U.S. Securities and Exchange Commission (SEC). The S-1/A filing itself is a key regulatory document, and ongoing compliance with securities laws is critical.
What Investors Should Do
- Monitor revenue growth trajectory, especially in the subscription segment.
- Assess the company's ability to secure future funding.
- Evaluate the sustainability of the current business model and revenue streams.
Key Dates
- 2025-03-31: End of Q1 2025 — Reported total revenue of $1,200,000 and a retained earnings deficit of -$10,000,000.
- 2024-12-31: End of Fiscal Year 2024 — Reported retained earnings deficit of -$10,500,000 and Series A Two Preferred Stock valued at $5,000,000.
- 2025-07-14: S-1/A Filing Date — Indicates ongoing efforts to raise capital and register securities, signaling strategic focus on future funding.
Glossary
- S-1/A
- An amendment to a registration statement filed with the SEC, typically used to update or correct information before securities are offered to the public. (This filing provides updated financial information and outlines the company's strategy and risks as it seeks to raise capital.)
- Retained Earnings
- The cumulative amount of net income that a company has retained over time, after paying out dividends. (A negative balance (accumulated deficit) indicates the company has incurred more losses than profits since its inception.)
- Series A Two Preferred Stock
- A class of preferred stock, often issued in early funding rounds, with specific rights and preferences over common stock. (Represents a significant component of the company's capital structure, valued at $5,000,000 as of December 31, 2024.)
- Subscription Revenue
- Revenue generated from recurring fees paid by customers for access to a service or product over a defined period. (This is the primary growth driver for OneMedNet, showing a 25% increase in Q1 2025.)
Year-Over-Year Comparison
The S-1/A filing shows a positive trend in revenue growth, with total revenue increasing by 20% year-over-year to $1.2M in Q1 2025, driven by a 25% surge in subscription revenue. While the retained earnings deficit has slightly improved from -$10.5M to -$10.0M, it still represents a significant accumulated loss. New risks related to capital raising efforts and the continued reliance on growth to achieve profitability are highlighted in this filing.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on July 14, 2025 regarding OneMedNet Corp (ONMDW).